Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Lymphoma

Explore clinical trials studying Central Nervous System Lymphoma. Study availability and eligibility vary by location and protocol.

34 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Lymphoma trial results

Completed

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

NCT01722305

Conditions
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma, Burkitt Lymphoma, Central Nervous System Lymphoma, +23 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma

NCT00221325

Conditions
Central Nervous System Lymphoma, Eye Neoplasms, Hemic and Lymphatic Diseases, +9 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Acalabrutinib in CNSL

NCT04906902

Conditions
Central Nervous System Lymphoma, Recurrent Central Nervous System Lymphoma, Refractory Central Nervous System Lymphoma
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions